{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:31:06Z","timestamp":1794335466286,"version":"4.9.0"},"reference-count":117,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR072615"],"award-info":[{"award-number":["R01 AR072615"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007588","name":"Washington State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human IFNs are secreted cytokines shown to stimulate the expression of over one thousand genes. These IFN-inducible genes primarily encode four major protein families, known as IFN-stimulated GTPases (ISGs), namely myxovirus-resistance proteins, guanylate-binding proteins (GBPs), p47 immunity-related GTPases and very large inducible guanosine triphosphate hydrolases (GTPases). These families respond specifically to type I or II IFNs and are well reported in coordinating immunity against some\u00a0well known as well as newly discovered viral, bacterial and parasitic infections. A growing body of evidence highlights the potential contributory and regulatory roles of ISGs in dysregulated inflammation and autoimmune diseases. Our focus was to draw attention to studies that demonstrate increased expression of ISGs in the serum and affected tissues of patients with RA, SS, lupus, IBD and psoriasis. In this review, we analysed emerging literature describing the potential roles of ISGs, particularly the GBP family, in the context of autoimmunity. We also highlighted the promise and implications for therapeutically targeting IFNs and GBPs in the treatment of rheumatic diseases.<\/jats:p>","DOI":"10.1093\/rheumatology\/keaa609","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T19:12:49Z","timestamp":1598382769000},"page":"494-506","source":"Crossref","is-referenced-by-count":38,"title":["Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1462-5250","authenticated-orcid":false,"given":"Mahamudul","family":"Haque","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby J","family":"Siegel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Fox","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salahuddin","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA"},{"name":"Division of Rheumatology, University of Washington School of Medicine, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"key":"2021020119153629100_keaa609-B1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev.cellbio.22.010305.104619","article-title":"The interferon-inducible GTPases","volume":"22","author":"Martens","year":"2006","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2021020119153629100_keaa609-B2","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1016\/j.jmb.2016.04.032","article-title":"Interferon-inducible GTPases in host resistance, inflammation and disease","volume":"428","author":"Pilla-Moffett","year":"2016","journal-title":"J Mol Biol"},{"key":"2021020119153629100_keaa609-B3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jbspin.2009.03.012","article-title":"Interferons and autoimmune disorders","volume":"76","author":"Meyer","year":"2009","journal-title":"Joint Bone Spine"},{"key":"2021020119153629100_keaa609-B4","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front Immunol"},{"key":"2021020119153629100_keaa609-B5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/icb.2012.9","article-title":"The interferons and their receptors\u2014distribution and regulation","volume":"90","author":"de Weerd","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"2021020119153629100_keaa609-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00005-019-00564-3","article-title":"Type III interferons (lambda interferons) in rheumatic autoimmune diseases","volume":"68","author":"Mora-Arias","year":"2020","journal-title":"Arch Immunol Ther Exp"},{"key":"2021020119153629100_keaa609-B7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon\u2013mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"2021020119153629100_keaa609-B8","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","article-title":"Interferon target-gene expression and epigenomic signatures in health and disease","volume":"20","author":"Barrat","year":"2019","journal-title":"Nat Immunol"},{"key":"2021020119153629100_keaa609-B9","first-page":"1662","article-title":"Type I interferon\u2013mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy","volume":"56","author":"Psarras","year":"2017","journal-title":"Rheumatology"},{"key":"2021020119153629100_keaa609-B10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/jir.2010.0102","article-title":"The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase","volume":"31","author":"Vestal","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"2021020119153629100_keaa609-B11","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.biochi.2007.04.015","article-title":"Interferon-induced Mx proteins in antiviral host defense","volume":"89","author":"Haller","year":"2007","journal-title":"Biochimie"},{"key":"2021020119153629100_keaa609-B12","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.micinf.2007.09.004","article-title":"Control of IFN-gamma\u2013mediated host resistance to intracellular pathogens by immunity-related GTPases (p47 GTPases)","volume":"9","author":"Taylor","year":"2007","journal-title":"Microbes Infect"},{"key":"2021020119153629100_keaa609-B13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"2021020119153629100_keaa609-B14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"2021020119153629100_keaa609-B15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mib.2004.12.012","article-title":"Immune control of phagosomal bacteria by p47 GTPases","volume":"8","author":"MacMicking","year":"2005","journal-title":"Curr Opin Microbiol"},{"key":"2021020119153629100_keaa609-B16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nri1270","article-title":"p47 GTPases: regulators of immunity to intracellular pathogens","volume":"4","author":"Taylor","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"2021020119153629100_keaa609-B17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1189\/jlb.3A0116-028RR","article-title":"Irgm1 is required for the inflammatory function of M1 macrophage in early experimental autoimmune encephalomyelitis","volume":"101","author":"Xu","year":"2017","journal-title":"J Leukoc Biol"},{"key":"2021020119153629100_keaa609-B18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molimm.2012.06.009","article-title":"Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood\u2013brain barrier and blood\u2013cerebrospinal fluid barrier","volume":"53","author":"Wang","year":"2013","journal-title":"Mol Immunol"},{"key":"2021020119153629100_keaa609-B19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jlb.58.4.477","article-title":"Identification of an endotoxin and IFN-inducible cDNA: possible identification of a novel protein family","volume":"58","author":"Sorace","year":"1995","journal-title":"J Leukoc Biol"},{"key":"2021020119153629100_keaa609-B20","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.4049\/jimmunol.148.10.3275","article-title":"The IRG-47 gene is IFN-gamma induced in B cells and encodes a protein with GTP-binding motifs","volume":"148","author":"Gilly","year":"1992","journal-title":"J Immunol"},{"key":"2021020119153629100_keaa609-B21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.it.2004.08.010","article-title":"IFN-inducible GTPases and immunity to intracellular pathogens","volume":"25","author":"MacMicking","year":"2004","journal-title":"Trends Immunol"},{"key":"2021020119153629100_keaa609-B22","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fimmu.2019.00902","article-title":"Dynamics of the type I interferon response during immunosuppressive therapy in rheumatoid arthritis","volume":"10","author":"de Jong","year":"2019","journal-title":"Front Immunol"},{"key":"2021020119153629100_keaa609-B23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13075-019-2034-4","article-title":"Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin","volume":"21","author":"Lambers","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2021020119153629100_keaa609-B24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/nan.12498","article-title":"Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis","volume":"45","author":"Soponkanaporn","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2021020119153629100_keaa609-B25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2018.02.001","article-title":"TBK1: a key regulator and potential treatment target for interferon positive Sj\u00f6gren\u2019s syndrome, systemic lupus erythematosus and systemic sclerosis","volume":"91","author":"Bodewes","year":"2018","journal-title":"J Autoimmun"},{"key":"2021020119153629100_keaa609-B26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13075-017-1501-z","article-title":"Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?","volume":"20","author":"Wahadat","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2021020119153629100_keaa609-B27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fimmu.2017.00285","article-title":"Type I interferon gene response is increased in early and established rheumatoid arthritis and correlates with autoantibody production","volume":"8","author":"Casta\u00f1eda-Delgado","year":"2017","journal-title":"Front Immunol"},{"key":"2021020119153629100_keaa609-B28","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.4049\/jimmunol.173.4.2815","article-title":"Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis","volume":"173","author":"Lande","year":"2004","journal-title":"J Immunol"},{"key":"2021020119153629100_keaa609-B29","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3819","article-title":"The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients","volume":"14","author":"Raterman","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2021020119153629100_keaa609-B30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/annrheumdis-2012-202552","article-title":"MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren\u2019s syndrome","volume":"73","author":"Maria","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021020119153629100_keaa609-B31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-\u03b1 inhibitors in patients with rheumatologic conditions","volume":"143","author":"de Gannes","year":"2007","journal-title":"Arch Dermatol"},{"key":"2021020119153629100_keaa609-B32","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4049\/jimmunol.171.3.1255","article-title":"A giant GTPase, very large inducible GTPase-1, is inducible by IFNs","volume":"171","author":"Klamp","year":"2003","journal-title":"J Immunol"},{"key":"2021020119153629100_keaa609-B33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.dci.2008.08.006","article-title":"Genes associated with an effective host response by Chinook salmon to Renibacterium salmoninarum","volume":"33","author":"Rhodes","year":"2009","journal-title":"Dev Comp Immunol"},{"key":"2021020119153629100_keaa609-B34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1084\/jem.20182031","article-title":"Interferon-induced guanylate-binding proteins: guardians of host defense in health and disease","volume":"216","author":"Tretina","year":"2019","journal-title":"J Exp Med"},{"key":"2021020119153629100_keaa609-B35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/35000617","article-title":"Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins","volume":"403","author":"Prakash","year":"2000","journal-title":"Nature"},{"key":"2021020119153629100_keaa609-B36","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1128\/JVI.02718-15","article-title":"Guanylate-binding protein 1, an interferon-induced GTPase, exerts an antiviral activity against classical swine fever virus depending on its GTPase activity","volume":"90","author":"Li","year":"2016","journal-title":"J Virol"},{"key":"2021020119153629100_keaa609-B37","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1093\/emboj\/20.20.5568","article-title":"The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines","volume":"20","author":"Guenzi","year":"2001","journal-title":"EMBO J"},{"key":"2021020119153629100_keaa609-B38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.chom.2016.02.019","article-title":"Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity","volume":"19","author":"Krapp","year":"2016","journal-title":"Cell Host Microbe"},{"key":"2021020119153629100_keaa609-B39","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0002-9440(10)64452-5","article-title":"Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases","volume":"161","author":"Lubeseder-Martellato","year":"2002","journal-title":"Am J Pathol"},{"key":"2021020119153629100_keaa609-B40","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1582-4934.2010.01146.x","article-title":"Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases","volume":"15","author":"Hammon","year":"2011","journal-title":"J Cell Mol Med"},{"key":"2021020119153629100_keaa609-B41","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"2021020119153629100_keaa609-B42","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1093\/hmg\/10.17.1793","article-title":"Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies","volume":"10","author":"Bowcock","year":"2001","journal-title":"Hum Mol Genet"},{"key":"2021020119153629100_keaa609-B43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1600-0625.2010.01160.x","article-title":"Increased expression of guanylate binding protein-1 in lesional skin of patients with cutaneous lupus erythematosus","volume":"20","author":"Naschberger","year":"2011","journal-title":"Exp Dermatol"},{"key":"2021020119153629100_keaa609-B44","first-page":"2360","article-title":"Interferon gamma counteracts the angiogenic switch and induces vascular permeability in dextran sulfate sodium colitis in mice","volume":"21","author":"Haep","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2021020119153629100_keaa609-B45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/carcin\/bgs310","article-title":"GBP-1 acts as a tumor suppressor in colorectal cancer cells","volume":"34","author":"Britzen-Laurent","year":"2013","journal-title":"Carcinogenesis"},{"key":"2021020119153629100_keaa609-B46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/mi.2008.62","article-title":"Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-\u03b3 and regulates barrier function through effects on apoptosis","volume":"2","author":"Schnoor","year":"2009","journal-title":"Mucosal Immunol"},{"key":"2021020119153629100_keaa609-B47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000460294","article-title":"Inducible GBP5 mediates the antiviral response via interferon-related pathways during influenza A virus infection","volume":"9","author":"Feng","year":"2017","journal-title":"J Innate Immun"},{"key":"2021020119153629100_keaa609-B48","doi-asserted-by":"crossref","first-page":"e00632","DOI":"10.1128\/JVI.00632-17","article-title":"Guanylate-binding protein 1 inhibits nuclear delivery of Kaposi\u2019s Sarcoma-associated herpesvirus virions by disrupting formation of actin filament","volume":"91","author":"Zou","year":"2017","journal-title":"J Virol"},{"key":"2021020119153629100_keaa609-B49","doi-asserted-by":"crossref","first-page":"20054","DOI":"10.1074\/jbc.M111.249326","article-title":"The interferon-\u03b3\u2013induced GTPase, mGBP-2, inhibits tumor necrosis factor \u03b1 (TNF-\u03b1) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-\u03baB and Rac protein","volume":"286","author":"Balasubramanian","year":"2011","journal-title":"J Biol Chem"},{"key":"2021020119153629100_keaa609-B50","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/jcb.29358","article-title":"Guanylate-binding protein-2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel-resistant colorectal cancer cells by interfering Wnt signaling","volume":"121","author":"Wang","year":"2020","journal-title":"J Cell Biochem"},{"key":"2021020119153629100_keaa609-B51","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/ar290","article-title":"The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1\/Th2 paradigm in autoimmunity","volume":"3","author":"Theofilopoulos","year":"2001","journal-title":"Arthritis Res"},{"key":"2021020119153629100_keaa609-B52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrrheum.2015.8","article-title":"Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges","volume":"11","author":"Smolen","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"2021020119153629100_keaa609-B53","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature06894","article-title":"Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell\u2013derived population","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"2021020119153629100_keaa609-B54","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ Res"},{"key":"2021020119153629100_keaa609-B55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/BOR.0b013e328337c95a","article-title":"Angiogenesis and vasculogenesis in rheumatoid arthritis","volume":"22","author":"Szekanecz","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"2021020119153629100_keaa609-B56","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/art.22706","article-title":"The role of vascular cell adhesion molecule 1\/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium","volume":"56","author":"Silverman","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021020119153629100_keaa609-B57","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.0000151875.21836.AE","article-title":"Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis","volume":"111","author":"Grisar","year":"2005","journal-title":"Circulation"},{"key":"2021020119153629100_keaa609-B58","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1083\/jcb.116.2.545","article-title":"A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44","volume":"116","author":"Lee","year":"1992","journal-title":"J Cell Biol"},{"key":"2021020119153629100_keaa609-B59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1042\/BST0340446","article-title":"TSG-6: a pluripotent inflammatory mediator?","volume":"34","author":"Milner","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"2021020119153629100_keaa609-B60","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.matbio.2018.01.011","article-title":"TSG-6: a multifunctional protein with anti-inflammatory and tissue-protective properties","volume":"78\u20139","author":"Day","year":"2019","journal-title":"Matrix Biol"},{"key":"2021020119153629100_keaa609-B61","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1242\/jcs.00407","article-title":"TSG-6: a multifunctional protein associated with inflammation","volume":"116","author":"Milner","year":"2003","journal-title":"J Cell Sci"},{"key":"2021020119153629100_keaa609-B62","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1002\/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E","article-title":"Amelioration of collagen-induced arthritis in DBA\/1J mice by recombinant TSG-6, a tumor necrosis factor\/interleukin-1-inducible protein","volume":"43","author":"Mindrescu","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2021020119153629100_keaa609-B63","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/art.10503","article-title":"Reduced susceptibility to collagen-induced arthritis in DBA\/1J mice expressing the TSG-6 transgene","volume":"46","author":"Mindrescu","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021020119153629100_keaa609-B64","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/art.10555","article-title":"Cartilage-specific constitutive expression of TSG-6 protein (product of tumor necrosis factor alpha-stimulated gene 6) provides a chondroprotective, but not antiinflammatory, effect in antigen-induced arthritis","volume":"46","author":"Glant","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2021020119153629100_keaa609-B65","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"2021020119153629100_keaa609-B66","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"key":"2021020119153629100_keaa609-B67","doi-asserted-by":"crossref","first-page":"i65","DOI":"10.1136\/ard.59.suppl_1.i65","article-title":"The role of angiogenesis in rheumatoid arthritis: recent developments","volume":"59(Suppl 1","author":"Koch","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"2021020119153629100_keaa609-B68","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1186\/ar575","article-title":"Angiogenesis in rheumatoid arthritis","volume":"4","author":"Paleolog","year":"2002","journal-title":"Arthritis Res"},{"key":"2021020119153629100_keaa609-B69","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1093\/emboj\/cdg382","article-title":"The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression","volume":"22","author":"Guenzi","year":"2003","journal-title":"EMBO J"},{"key":"2021020119153629100_keaa609-B70","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.celrep.2019.04.063","article-title":"Guanylate-binding proteins 2 and 5 exert broad antiviral activity by inhibiting furin-mediated processing of viral envelope proteins","volume":"27","author":"Braun","year":"2019","journal-title":"Cell Rep"},{"key":"2021020119153629100_keaa609-B71","doi-asserted-by":"crossref","first-page":"e1073","DOI":"10.1002\/cti2.1073","article-title":"Furin-mediated protein processing in infectious diseases and cancer","volume":"8","author":"Braun","year":"2019","journal-title":"Clin Transl Immunol"},{"key":"2021020119153629100_keaa609-B72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/13543776.2014.1000303","article-title":"Therapeutic uses of furin and its inhibitors: a patent review","volume":"25","author":"Couture","year":"2015","journal-title":"Expert Opin Ther Pat"},{"key":"2021020119153629100_keaa609-B73","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-5793(96)00861-7","article-title":"Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2","volume":"393","author":"Sato","year":"1996","journal-title":"FEBS Lett"},{"key":"2021020119153629100_keaa609-B74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-5793(03)01159-1","article-title":"TACE\/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity","volume":"554","author":"Srour","year":"2003","journal-title":"FEBS Lett"},{"key":"2021020119153629100_keaa609-B75","doi-asserted-by":"crossref","first-page":"4895050","DOI":"10.1155\/2016\/4895050","article-title":"A tale of two joints: the role of matrix metalloproteases in cartilage biology","volume":"2016","author":"Rose","year":"2016","journal-title":"Dis Markers"},{"key":"2021020119153629100_keaa609-B76","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.4049\/jimmunol.167.9.5150","article-title":"Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-\u03b3 and IFN-\u03b2: critical role of STAT-1\u03b1","volume":"167","author":"Ma","year":"2001","journal-title":"J Immunol"},{"key":"2021020119153629100_keaa609-B77","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1016\/j.febslet.2005.09.012","article-title":"Inhibition of matrix metalloproteinase-9 by interferons and TGF-\u03b21 through distinct signalings accounts for reduced monocyte invasiveness","volume":"579","author":"Nguyen","year":"2005","journal-title":"FEBS Lett"},{"key":"2021020119153629100_keaa609-B78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/OARRR.S167783","article-title":"Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus: links and risks","volume":"11","author":"Pasoto","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"2021020119153629100_keaa609-B79","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/acr.20289","article-title":"Preclinical validation of salivary biomarkers for primary Sj\u00f6gren\u2019s syndrome","volume":"62","author":"Hu","year":"2010","journal-title":"Arthritis Care Res"},{"key":"2021020119153629100_keaa609-B80","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.21006","article-title":"Gene expression profiling of minor salivary glands clearly distinguishes primary Sj\u00f6gren\u2019s syndrome patients from healthy control subjects","volume":"52","author":"Hjelmervik","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021020119153629100_keaa609-B81","doi-asserted-by":"crossref","first-page":"102335","DOI":"10.1016\/j.jaut.2019.102335","article-title":"Autoimmune epithelitis (Sj\u00f6gren\u2019s syndrome); the impact of metabolic status of glandular epithelial cells on auto-immunogenicity","volume":"104","author":"Katsiougiannis","year":"2019","journal-title":"J Autoimmun"},{"key":"2021020119153629100_keaa609-B82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yexcr.2018.07.033","article-title":"Guanylate binding protein-1\u2013mediated epithelial barrier in human salivary gland duct epithelium","volume":"371","author":"Konno","year":"2018","journal-title":"Exp Cell Res"},{"key":"2021020119153629100_keaa609-B83","doi-asserted-by":"crossref","first-page":"e100926","DOI":"10.15252\/embj.2018100926","article-title":"Human GBP1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis","volume":"38","author":"Fisch","year":"2019","journal-title":"EMBO J"},{"key":"2021020119153629100_keaa609-B84","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1217141","article-title":"GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals","volume":"336","author":"Shenoy","year":"2012","journal-title":"Science"},{"key":"2021020119153629100_keaa609-B85","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/1529-0131(200012)43:12<2807::AID-ANR22>3.0.CO;2-M","article-title":"Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"43","author":"P\u00e9rez","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2021020119153629100_keaa609-B86","doi-asserted-by":"crossref","first-page":"383","DOI":"10.17219\/acem\/30428","article-title":"The significance of matrix metalloproteinases in oral diseases","volume":"25","author":"Maciejczyk","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"2021020119153629100_keaa609-B87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cca.2009.03.018","article-title":"Proteome analysis of gelatin-bound salivary proteins in patients with primary Sj\u00f6gren\u2019s Syndrome: identification of matrix metalloproteinase-9","volume":"403","author":"Ito","year":"2009","journal-title":"Clin Chim Acta"},{"key":"2021020119153629100_keaa609-B88","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jid.2019.11.016","article-title":"Staphylococcus aureus colonization is increased on lupus skin lesions and is promoted by IFN-mediated barrier disruption","volume":"140","author":"Sirobhushanam","year":"2020","journal-title":"J Invest Dermatol"},{"key":"2021020119153629100_keaa609-B89","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/BOR.0000000000000704","article-title":"Treatment of cutaneous lupus erythematosus: current approaches and future strategies","volume":"32","author":"Shi","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"2021020119153629100_keaa609-B90","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/annrheumdis-2018-213197","article-title":"Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa","volume":"77","author":"Sarkar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021020119153629100_keaa609-B91","first-page":"668","article-title":"STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE","volume":"59","author":"De Groof","year":"2020","journal-title":"Rheumatology"},{"key":"2021020119153629100_keaa609-B92","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3389\/fimmu.2018.02746","article-title":"Psoriasis: classical vs. paradoxical. The Yin-Yang of TNF and type I interferon","volume":"9","author":"Mylonas","year":"2018","journal-title":". Front Immunol"},{"key":"2021020119153629100_keaa609-B93","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3389\/fphar.2019.00872","article-title":"Mini review: new treatments in psoriatic arthritis. Focus on the IL-23\/17 axis","volume":"10","author":"Sakkas","year":"2019","journal-title":"Front Pharmacol"},{"key":"2021020119153629100_keaa609-B94","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1080\/21645515.2017.1356498","article-title":"Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis","volume":"13","author":"Jeon","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"2021020119153629100_keaa609-B95","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"2021020119153629100_keaa609-B96","doi-asserted-by":"crossref","first-page":"e1002097","DOI":"10.1371\/journal.pgen.1002097","article-title":"Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis","volume":"7","author":"Marquis","year":"2011","journal-title":"PLoS Genet"},{"key":"2021020119153629100_keaa609-B97","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3389\/fimmu.2019.01726","article-title":"Additive or synergistic interactions between IL-17A or IL-17F and TNF or IL-1\u03b2 depend on the cell type","volume":"10","author":"Noack","year":"2019","journal-title":"Front Immunol"},{"key":"2021020119153629100_keaa609-B98","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3748\/wjg.v17.i5.578","article-title":"Role of the endothelium in inflammatory bowel diseases","volume":"17","author":"Cromer","year":"2011","journal-title":"World J Gastroenterol"},{"key":"2021020119153629100_keaa609-B99","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2021020119153629100_keaa609-B100","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2011.02.016","article-title":"Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"Strober","year":"2011","journal-title":"Gastroenterology"},{"key":"2021020119153629100_keaa609-B101","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.rdc.2009.12.008","article-title":"Interferon-alpha: a therapeutic target in systemic lupus erythematosus","volume":"36","author":"Crow","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"2021020119153629100_keaa609-B102","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/art.23062","article-title":"Augmented interferon-\u03b1 pathway activation in patients with Sj\u00f6gren\u2019s syndrome treated with etanercept","volume":"56","author":"Mavragani","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021020119153629100_keaa609-B103","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1196\/annals.1447.031","article-title":"IFN-\u03b1 can both protect against and promote the development of type 1 diabetes","volume":"1150","author":"Wong","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"2021020119153629100_keaa609-B104","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1089\/hum.2006.17.985","article-title":"Intraarticular interferon-\u03b2 gene therapy ameliorates adjuvant arthritis in rats","volume":"17","author":"Adriaansen","year":"2006","journal-title":"Hum Gene Ther"},{"key":"2021020119153629100_keaa609-B105","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1002\/art.21496","article-title":"Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-\u03b2\u2013deficient mice","volume":"52","author":"Treschow","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021020119153629100_keaa609-B106","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI124466","article-title":"Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus","volume":"129","author":"Furie","year":"2019","journal-title":"J Clin Invest"},{"key":"2021020119153629100_keaa609-B107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"2021020119153629100_keaa609-B108","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.4049\/jimmunol.1400205","article-title":"Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23\/IL-17 axis","volume":"193","author":"Works","year":"2014","journal-title":"J Immunol"},{"key":"2021020119153629100_keaa609-B109","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.apsb.2018.07.005","article-title":"High-throughput screening for small molecule inhibitors of the type-I interferon signaling pathway","volume":"8","author":"Yuliantie","year":"2018","journal-title":"Acta Pharm Sin B"},{"key":"2021020119153629100_keaa609-B110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2014.07.003","article-title":"Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis \u2013 xenograft model","volume":"55","author":"Kundu-Raychaudhuri","year":"2014","journal-title":"J Autoimmun"},{"key":"2021020119153629100_keaa609-B111","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.it.2008.07.002","article-title":"How interferon-\u03b3 keeps autoimmune diseases in check","volume":"29","author":"Kelchtermans","year":"2008","journal-title":"Trends Immunol"},{"key":"2021020119153629100_keaa609-B112","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S1567-5769(03)00131-0","article-title":"Anti-inflammatory properties of pro-inflammatory interferon-\u03b3","volume":"3","author":"M\u00fchl","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"2021020119153629100_keaa609-B113","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/25785826.2020.1751908","article-title":"New insights into IFN-\u03b3 in rheumatoid arthritis: role in the era of JAK inhibitors","volume":"43","author":"Kato","year":"2020","journal-title":"Immunol Med"},{"key":"2021020119153629100_keaa609-B114","doi-asserted-by":"crossref","first-page":"e000339","DOI":"10.1136\/lupus-2019-000339","article-title":"Varicella zoster virus infections increase the risk of disease flares in patients with SLE: a matched cohort study","volume":"6","author":"Sun","year":"2019","journal-title":"Lupus Sci Med"},{"key":"2021020119153629100_keaa609-B115","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/1346-8138.13755","article-title":"Varicella zoster virus meningitis under ustekinumab because of plaque psoriasis","volume":"44","author":"St\u00f6llberger","year":"2017","journal-title":"J Dermatol"},{"key":"2021020119153629100_keaa609-B116","doi-asserted-by":"crossref","first-page":"e01151","DOI":"10.1128\/JVI.01151-18","article-title":"Distinctive roles for type I and type II interferons and interferon regulatory factors in the host cell defense against Varicella-Zoster virus","volume":"92","author":"Sen","year":"2018","journal-title":"J Virol"},{"key":"2021020119153629100_keaa609-B117","doi-asserted-by":"crossref","first-page":"e00257\u201319","DOI":"10.1128\/JVI.00257-19","article-title":"Interferon gamma inhibits Varicella-Zoster virus replication in a cell line\u2013dependent manner","volume":"93","author":"Shakya","year":"2019","journal-title":"J Virol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/494\/36167979\/keaa609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/2\/494\/36167979\/keaa609.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:32:51Z","timestamp":1696581171000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/2\/494\/5960203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":117,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,11,7]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa609","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,11,7]]}}}